A Special Purpose Acquisition Corporation (SPAC) executive tells INN why SPACs offer investors a free preview into the cannabis world.

At the core, SPACs are an investment vehicle in which a company raises capital through an initial public offering (IPO) before any operations are determined. Once the total sum is raised the goal becomes for the company to go out, find and acquire an operating business.


SPACs have a time limit agreed with investors and if the company does not meet its end of the bargain, the money goes back to the investors.

Joe Crouthers is the chairman and CEO of Ceres Acquisition (NEO:CERE.UN), a SPAC looking into the cannabis business which went public on the NEO Exchange in March after raising US$120 million.

Ceres has not completed its acquisition but Crouthers told INN the company is heavily interested in the US cannabis market.

The executive described SPACs, particularly those in cannabis, as a free look for investors interested in the market.

But Crouthers and Ceres are not newcomers to cannabis investments. In fact, Ceres will continue to invest through its holding company.

What Ceres will hope sets it apart is its attention to consumer and more directly the marketing of cannabis products to consumers.

“We brought on two different talent management firms to sort of open the top of the funnel in terms of consumer awareness, consumer access or finding creative ways to get in front of consumers.” Crouthers said.

As part of its public listing, Jos Schmitt, president and CEO of NEO, praised Ceres for a deep understanding of the cannabis industry’s evolution.

“Go-to-market efficiency and tailored client-service has driven our leadership in the Canadian SPAC space, and we believe this is just the beginning of an exciting year for SPAC transactions, not only in the cannabis sector but across many industries,” Schmitt said.

Crouthers told INN his company went with the NEO for its listing since the exchange has been a great partner for this investment model. The NEO has become a hub of sorts for cannabis SPACs.

The executive said there will be a day when US companies touching the cannabis plant will be allowed to list in US-based senior exchanges but at the moment that timeline didn’t align with the company.

“Even if you get your rescheduling in the US, our view is it’ll take several months for the exchanges to get ready to do that,” the SPAC executive said.

Listings in senior exchanges, like the NASDAQ or the New York Stock Exchange, are not currently permitted for cannabis companies operating in the US, given the federal restrictions of the drug. However, Canadian-based companies have secured these listings by maintaining a distance from any plant-touching business below the border.

The company reached the public markets just before the full effects of the COVID-19 pandemic took on the global markets, an aspect Crouthers said gave the firm a chance to become more efficient in its acquisition pursuit.

“I’m very excited about where we’re headed, but no, I don’t have an exact timeline yet on it,” he told INN.

Don’t forget to follow us @INN_Cannabis for real-time news updates!

Securities Disclosure: I, Bryan Mc Govern, hold no direct investment interest in any company mentioned in this article.

Editorial Disclosure: The Investing News Network does not guarantee the accuracy or thoroughness of the information reported in the interviews it conducts. The opinions expressed in these interviews do not reflect the opinions of the Investing News Network and do not constitute investment advice. All readers are encouraged to perform their own due diligence.

US Election 2020 and Cannabis

 
Investing in cannabis? Read what experts have to say about cannabis and the US Election!
 
  • Q3 Systemwide Pro Forma Revenue increased 18% quarter-over-quarter to $22.3 million , 170% year-over-year – Company became cash flow positive from operations in August
  • Company sale leaseback transaction with Innovative Industrial Properties scheduled to close within two weeks. As a result of close, together with proceeds from the recently closed bought deal financing, the Company will have $16 million of cash and $43 million in long-term debt
  • Company is in the process of acquiring acreage to construct up to 210,000 square feet of flowering canopy and supporting manufacturing facility in Cook County, Illinois to exponentially increase capacity in state
  • Initial guidance for 2021 with Systemwide Pro Forma Revenue of $170 -180 million and Adjusted EBITDA of $40 -50 million
  • The Company’s existing projects at maturity represent a long-term revenue and EBITDA opportunity upwards of $650 million and $250 million

4Front Ventures Corp. (CSE: FFNT) (OTCQX: FFNTF) (” 4Front ” or the ” Company “) today announced its financial results for the third quarter of 2020. All financial information is presented in U.S. dollars unless otherwise indicated.

Third Quarter 2020 Financial Results Highlights

Keep reading... Show less
  • Q3 Systemwide Pro Forma Revenue increased 18% quarter-over-quarter to $22.3 million , 170% year-over-year – Company became cash flow positive from operations in August
  • Company sale leaseback transaction with Innovative Industrial Properties scheduled to close within two weeks. As a result of close, together with proceeds from the recently closed bought deal financing, the Company will have $16 million of cash and $43 million in long-term debt
  • Company is in the process of acquiring acreage to construct up to 210,000 square feet of flowering canopy and supporting manufacturing facility in Cook County, Illinois to exponentially increase capacity in state
  • Initial guidance for 2021 with Systemwide Pro Forma Revenue of $170 -180 million and Adjusted EBITDA of $40 -50 million
  • The Company’s existing projects at maturity represent a long-term revenue and EBITDA opportunity upwards of $650 million and $250 million

4Front Ventures Corp. (CSE: FFNT) (OTCQX: FFNTF) (” 4Front ” or the ” Company “) today announced its financial results for the third quarter of 2020. All financial information is presented in U.S. dollars unless otherwise indicated.

Third Quarter 2020 Financial Results Highlights

Keep reading... Show less

Shareholders with losses exceeding $50,000 are encouraged to contact the firm

The Law Offices of Frank R. Cruz reminds investors of the upcoming December 1, 2020 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased Aurora Cannabis, Inc. (“Aurora” or the “Company”) (NYSE: ACB ) securities between February 13, 2020 and September 4, 2020 , inclusive (the “Class Period”).

Keep reading... Show less

Lobe Sciences Ltd. (CSE: LOBE) (OTC Pink: GTSIF) (“Lobe” or the “Company”) is pleased to announce the launch of preclinical research studies using psilocybin and N-Acetylcysteine (“NAC”) for the treatment of mild traumatic brain injuryconcussion (“mTBI”) with post-traumatic stress disorder (“PTSD”). The study is in collaboration with a multidisciplinary team of scientists and physicians at the University of Miami Miller School of Medicine under the lead of Michael E. Hoffer, M.D., professor of otolaryngology and neurological surgery.

NAC has been shown to be safe and efficacious in a phase I human clinical study in treating military personnel who had suffered mTBI. The initial research focus is to demonstrate the safety and efficacy of the combination of psilocybin and NAC using broadly accepted rodent models. Final results are expected in 2021. Once this is established, more specific work can examine dose response, medicine uptake, and medicine levels. The research team at the Miller School of Medicine has conducted prior studies involving NAC with mTBI and has a license from the United States Drug Enforcement Administration to conduct research using Schedule I controlled substances, which includes psilocybin.

Keep reading... Show less

Aphria Inc. (” Aphria “, ” we ” or the ” Company “) (TSX: APHA) (NASDAQ: APHA), a leading global cannabis company inspiring and empowering the worldwide community to live their very best life, announced it has closed the accretive, strategic acquisition (the ” Acquisition “) of  SW Brewing Company, LLC (” SweetWater Brewing Company ” or ” SweetWater “), one of the largest independent craft brewers in the United States (“U.S.”) based on volume. Beginning with the flagship 420 beverage offerings, SweetWater has created an award-winning lineup of year-round, seasonal and specialty beers, a portfolio of brands closely aligned with a cannabis lifestyle.

Keep reading... Show less